MARKET

BETRF

BETRF

Betterlife Pharma Inc
OTCMQB
0.033
-0.001
-2.65%
Closed 11:50 01/16 EST
OPEN
0.033
PREV CLOSE
0.034
HIGH
0.033
LOW
0.033
VOLUME
42.23K
TURNOVER
1.40K
52 WEEK HIGH
0.120
52 WEEK LOW
0.028
MARKET CAP
5.03M
P/E (TTM)
-3.4842
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BETRF last week (0112-0116)?
Weekly Report · 13h ago
Weekly Report: what happened at BETRF last week (0105-0109)?
Weekly Report · 01/12 10:42
BetterLife Pharma Targets Global Partners for BETR-001 at JPM Week Forums
TipRanks · 01/06 14:18
BetterLife Pharma to Participate in YAFO Capital Access Asia Partnering Forum During JPM Week in San Francisco
Newsfile · 01/06 13:00
Weekly Report: what happened at BETRF last week (1229-0102)?
Weekly Report · 01/05 10:35
Weekly Report: what happened at BETRF last week (1222-1226)?
Weekly Report · 12/29/2025 10:34
BetterLife Pharma Director and Audit Chair Robert Metcalfe Resigns
TipRanks · 12/24/2025 01:15
Weekly Report: what happened at BETRF last week (1215-1219)?
Weekly Report · 12/22/2025 10:34
More
About BETRF
BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical, is a non-hallucinogenic second-generation lysergic acid diethylamide (LSD) derivative molecule that mimics the projected therapeutic potential of LSD in the treatment of disorders, such as depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical, is a formulation of a derivative of dihydrohonokiol, a known anti-anxiety compound, with the potential for treatment of anxiety related disorders, including benzodiazepine dependency. It is also refining and developing drug candidates from a set of complementary interferon-based technologies, which have the potential to engage the immune system to fight viral infections.

Webull offers BetterLife Pharma Inc stock information, including OTCMQB: BETRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BETRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BETRF stock methods without spending real money on the virtual paper trading platform.